Funding for the Longevity Industry Continues, Even in a Poor Market

Source https://www.fightaging.org/archives/2023/10/funding-for-the-longevity-industry-continues-even-in-a-poor-market/

Setting aside the movements of the broader market from year to year, and noting that this past year has been a poor time for venture funding, we should expect the funding available for biotech companies in the longevity industry to continue to increase in the years ahead. The fundamental reasons for this trend appear at the end of this article: the science looks very promising, there are many good projects sitting on the sidelines waiting for a champion to take them forward, and the upside for investors seems high. A therapy that targets one or more underlying mechanisms of aging will likely be applicable to a long list of age-related conditions.

While the wonders of modern medicine helped to double global life expectancy between 1920 and 2020, human health span has not followed the upward trend. Today, more than ever, people are living more…

What Do You Think?

comments